Skip to content
lifestyle.thedailyhaze.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Biolexis Therapeutics Inc
Biolexis Therapeutics Presents First-in-Human Phase 1a Data for BLX-7006, an Oral Small-Molecule GLP-1 Receptor Agonist with a Structurally Distinct Allosteric Mechanism, at ObesityWeek® 2026
November 12, 2026